Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...

For Zevra Therapeutics and its rare neurodegenerative disease med arimoclomol, the second time’s the charm. | The ...

McEwan and James have now taken advantage of TRIM21’s cluster activation by turning it against another protein with a ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for ...

Study connects the swip-10 gene in roundworms to copper metabolism and neurodegeneration. Loss of swip-10 impairs copper ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Research enhances our comprehension of neurodegenerative diseases associated with protein aggregation. A recent study ...

Scientists discovered a link between copper regulation and neurodegeneration, using the worm gene swip-10. Their findings suggest that restoring copper balance could offer new treatments for disorders ...

This year's World Alzheimer's Day campaign aims to address the stigma and discrimination while highlighting global efforts to ...